Pharma Reviews: For Lupin in US, next 2 years will be a challenge, says Motilal Oswal

Gupta believes that the domestic market can continue recording a 12% ... Gupta has categorised the evolution of the Indian pharmaceutical industry ...
Read more: For Lupin in US, next 2 years will be a challenge, says Motilal Oswal